Q0144 HCPCS Level II code: Azithromycin dihydrate, oral, capsules/powder, 1 gram
Q0144 is the HCPCS code for “Azithromycin dihydrate, oral, capsules/powder, 1 gram” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
Q0144Azithromycin dihydrate, oral, capsules/powder, 1 gram
Short description: Azithromycin dihydrate, oral
HCPCS · United States
Notes for Q0144
As CMS prints them, with any note Q0144 takes from the headings above it.
Note
- CMS processing note 0054: CODE Q0144 ESTABLISHED AS A NATIONAL CODE FOR MEDICAID USE.
Medicare details
The indicators CMS publishes with Q0144 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Non-covered by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jul 1, 1996
Where Q0144 sits
- 1Q codesTemporary codes
- 2Active code Q0144Azithromycin dihydrate, oral, capsules/powder, 1 gram
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code Q0144 mean?
Q0144 is the HCPCS code for “Azithromycin dihydrate, oral, capsules/powder, 1 gram” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover Q0144?
CMS lists Q0144’s Medicare coverage as “Non-covered by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q0144
All Q codesQ0112All potassium hydroxide (koh) preparationsQ0113Pinworm examinationsQ0114Fern testQ0115Post-coital direct, qualitative examinations of vaginal or cervical mucousQ0138Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)Q0139Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)Q0155Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy…Q0161Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy…Q0162Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to…Q0163Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy…Q0164Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy…Q0166Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy…